Harvard Bioscience (HBIO) EBIT (QoQ) (2010 - 2026)
Harvard Bioscience (HBIO) EBIT (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn |
| 10 | Harvard Bioscience | 28.05 Mn | 20.96 Mn | 12.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -168.65% |
| Dec 31, 2025 | 768.02% |
| Sep 30, 2025 | 124.05% |
| Jun 30, 2025 | 98.35% |
| Mar 31, 2025 | -451,627.27% |
| Dec 31, 2024 | 100.59% |
| Sep 30, 2024 | 9.42% |
| Jun 30, 2024 | 9.21% |
| Mar 31, 2024 | -908.16% |
| Dec 31, 2023 | 130.23% |
| Sep 30, 2023 | -217.21% |
| Jun 30, 2023 | -54.49% |
| Mar 31, 2023 | 482.71% |
| Dec 31, 2022 | 87.85% |
| Sep 30, 2022 | -194.10% |
| Jun 30, 2022 | 159.56% |
| Mar 31, 2022 | -495.06% |
| Dec 31, 2021 | 210.04% |
| Sep 30, 2021 | 844.83% |
| Jun 30, 2021 | 124.27% |